0.017665
0.000000
0.000000
0.000000
0.016434
0.000000
0.000000
0.000000
0.029533
0.00000
0.00000
0.00000
Matsushima, M.
Inaka, K.
Yamada, T.
Sekiguchi, K.
Kikuchi, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
90.00
90.00
56.610
60.850
33.860
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
Cl -1
35.453
CHLORIDE ION
non-polymer
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
268
10588
10592
8486712
Structural and functional analyses of the Arg-Gly-Asp sequence introduced into human lysozyme.
1993
US
Science
SCIEAS
0038
0036-8075
258
987
Structure of a Fibronectin Type III Domain from Tenascin Phased by MAD Analysis of the Selenomethionyl Protein
1992
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
266
12599
The Crystal Structure of a Mutant Human Lysozyme C77(Slash)95A with Increased Secretion Efficiency in Yeast
1991
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
x-ray
1
1.0
15137.105
HUMAN LYSOZYME
3.2.1.17
1
man
polymer
35.453
CHLORIDE ION
2
syn
non-polymer
18.015
water
82
nat
water
no
no
KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVRGDSNA
CHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV
KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVRGDSNA
CHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
1.93
36.14
pdbx_database_status
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1993-10-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1993-02-03
REL
REL
CL
CHLORIDE ION
HOH
water
CL
131
2
CL
CL
131
A
CL
132
2
CL
CL
132
A
HOH
135
3
HOH
HOH
135
A
HOH
136
3
HOH
HOH
136
A
HOH
137
3
HOH
HOH
137
A
HOH
138
3
HOH
HOH
138
A
HOH
139
3
HOH
HOH
139
A
HOH
140
3
HOH
HOH
140
A
HOH
141
3
HOH
HOH
141
A
HOH
142
3
HOH
HOH
142
A
HOH
143
3
HOH
HOH
143
A
HOH
144
3
HOH
HOH
144
A
HOH
145
3
HOH
HOH
145
A
HOH
146
3
HOH
HOH
146
A
HOH
147
3
HOH
HOH
147
A
HOH
149
3
HOH
HOH
149
A
HOH
150
3
HOH
HOH
150
A
HOH
151
3
HOH
HOH
151
A
HOH
154
3
HOH
HOH
154
A
HOH
156
3
HOH
HOH
156
A
HOH
157
3
HOH
HOH
157
A
HOH
158
3
HOH
HOH
158
A
HOH
159
3
HOH
HOH
159
A
HOH
160
3
HOH
HOH
160
A
HOH
161
3
HOH
HOH
161
A
HOH
162
3
HOH
HOH
162
A
HOH
163
3
HOH
HOH
163
A
HOH
165
3
HOH
HOH
165
A
HOH
166
3
HOH
HOH
166
A
HOH
167
3
HOH
HOH
167
A
HOH
168
3
HOH
HOH
168
A
HOH
171
3
HOH
HOH
171
A
HOH
172
3
HOH
HOH
172
A
HOH
173
3
HOH
HOH
173
A
HOH
174
3
HOH
HOH
174
A
HOH
175
3
HOH
HOH
175
A
HOH
176
3
HOH
HOH
176
A
HOH
177
3
HOH
HOH
177
A
HOH
178
3
HOH
HOH
178
A
HOH
179
3
HOH
HOH
179
A
HOH
181
3
HOH
HOH
181
A
HOH
183
3
HOH
HOH
183
A
HOH
184
3
HOH
HOH
184
A
HOH
185
3
HOH
HOH
185
A
HOH
186
3
HOH
HOH
186
A
HOH
187
3
HOH
HOH
187
A
HOH
188
3
HOH
HOH
188
A
HOH
189
3
HOH
HOH
189
A
HOH
190
3
HOH
HOH
190
A
HOH
191
3
HOH
HOH
191
A
HOH
192
3
HOH
HOH
192
A
HOH
193
3
HOH
HOH
193
A
HOH
194
3
HOH
HOH
194
A
HOH
195
3
HOH
HOH
195
A
HOH
197
3
HOH
HOH
197
A
HOH
198
3
HOH
HOH
198
A
HOH
199
3
HOH
HOH
199
A
HOH
200
3
HOH
HOH
200
A
HOH
201
3
HOH
HOH
201
A
HOH
202
3
HOH
HOH
202
A
HOH
203
3
HOH
HOH
203
A
HOH
204
3
HOH
HOH
204
A
HOH
207
3
HOH
HOH
207
A
HOH
208
3
HOH
HOH
208
A
HOH
209
3
HOH
HOH
209
A
HOH
210
3
HOH
HOH
210
A
HOH
211
3
HOH
HOH
211
A
HOH
212
3
HOH
HOH
212
A
HOH
213
3
HOH
HOH
213
A
HOH
215
3
HOH
HOH
215
A
HOH
216
3
HOH
HOH
216
A
HOH
217
3
HOH
HOH
217
A
HOH
218
3
HOH
HOH
218
A
HOH
220
3
HOH
HOH
220
A
HOH
221
3
HOH
HOH
221
A
HOH
222
3
HOH
HOH
222
A
HOH
225
3
HOH
HOH
225
A
HOH
227
3
HOH
HOH
227
A
HOH
228
3
HOH
HOH
228
A
HOH
231
3
HOH
HOH
231
A
HOH
232
3
HOH
HOH
232
A
HOH
233
3
HOH
HOH
233
A
HOH
239
3
HOH
HOH
239
A
HOH
241
3
HOH
HOH
241
A
LYS
1
n
1
LYS
1
A
VAL
2
n
2
VAL
2
A
PHE
3
n
3
PHE
3
A
GLU
4
n
4
GLU
4
A
ARG
5
n
5
ARG
5
A
CYS
6
n
6
CYS
6
A
GLU
7
n
7
GLU
7
A
LEU
8
n
8
LEU
8
A
ALA
9
n
9
ALA
9
A
ARG
10
n
10
ARG
10
A
THR
11
n
11
THR
11
A
LEU
12
n
12
LEU
12
A
LYS
13
n
13
LYS
13
A
ARG
14
n
14
ARG
14
A
LEU
15
n
15
LEU
15
A
GLY
16
n
16
GLY
16
A
MET
17
n
17
MET
17
A
ASP
18
n
18
ASP
18
A
GLY
19
n
19
GLY
19
A
TYR
20
n
20
TYR
20
A
ARG
21
n
21
ARG
21
A
GLY
22
n
22
GLY
22
A
ILE
23
n
23
ILE
23
A
SER
24
n
24
SER
24
A
LEU
25
n
25
LEU
25
A
ALA
26
n
26
ALA
26
A
ASN
27
n
27
ASN
27
A
TRP
28
n
28
TRP
28
A
MET
29
n
29
MET
29
A
CYS
30
n
30
CYS
30
A
LEU
31
n
31
LEU
31
A
ALA
32
n
32
ALA
32
A
LYS
33
n
33
LYS
33
A
TRP
34
n
34
TRP
34
A
GLU
35
n
35
GLU
35
A
SER
36
n
36
SER
36
A
GLY
37
n
37
GLY
37
A
TYR
38
n
38
TYR
38
A
ASN
39
n
39
ASN
39
A
THR
40
n
40
THR
40
A
ARG
41
n
41
ARG
41
A
ALA
42
n
42
ALA
42
A
THR
43
n
43
THR
43
A
ASN
44
n
44
ASN
44
A
TYR
45
n
45
TYR
45
A
ASN
46
n
46
ASN
46
A
ALA
47
n
47
ALA
47
A
GLY
48
n
48
GLY
48
A
ASP
49
n
49
ASP
49
A
ARG
50
n
50
ARG
50
A
SER
51
n
51
SER
51
A
THR
52
n
52
THR
52
A
ASP
53
n
53
ASP
53
A
TYR
54
n
54
TYR
54
A
GLY
55
n
55
GLY
55
A
ILE
56
n
56
ILE
56
A
PHE
57
n
57
PHE
57
A
GLN
58
n
58
GLN
58
A
ILE
59
n
59
ILE
59
A
ASN
60
n
60
ASN
60
A
SER
61
n
61
SER
61
A
ARG
62
n
62
ARG
62
A
TYR
63
n
63
TYR
63
A
TRP
64
n
64
TRP
64
A
CYS
65
n
65
CYS
65
A
ASN
66
n
66
ASN
66
A
ASP
67
n
67
ASP
67
A
GLY
68
n
68
GLY
68
A
LYS
69
n
69
LYS
69
A
THR
70
n
70
THR
70
A
PRO
71
n
71
PRO
71
A
GLY
72
n
72
GLY
72
A
ALA
73
n
73
ALA
73
A
VAL
74
n
74
VAL
74
A
ARG
74
n
75
A
ARG
74
A
GLY
74
n
76
B
GLY
74
A
ASP
74
n
77
C
ASP
74
A
SER
74
n
78
D
SER
74
A
ASN
75
n
79
ASN
75
A
ALA
76
n
80
ALA
76
A
CYS
77
n
81
CYS
77
A
HIS
78
n
82
HIS
78
A
LEU
79
n
83
LEU
79
A
SER
80
n
84
SER
80
A
CYS
81
n
85
CYS
81
A
SER
82
n
86
SER
82
A
ALA
83
n
87
ALA
83
A
LEU
84
n
88
LEU
84
A
LEU
85
n
89
LEU
85
A
GLN
86
n
90
GLN
86
A
ASP
87
n
91
ASP
87
A
ASN
88
n
92
ASN
88
A
ILE
89
n
93
ILE
89
A
ALA
90
n
94
ALA
90
A
ASP
91
n
95
ASP
91
A
ALA
92
n
96
ALA
92
A
VAL
93
n
97
VAL
93
A
ALA
94
n
98
ALA
94
A
CYS
95
n
99
CYS
95
A
ALA
96
n
100
ALA
96
A
LYS
97
n
101
LYS
97
A
ARG
98
n
102
ARG
98
A
VAL
99
n
103
VAL
99
A
VAL
100
n
104
VAL
100
A
ARG
101
n
105
ARG
101
A
ASP
102
n
106
ASP
102
A
PRO
103
n
107
PRO
103
A
GLN
104
n
108
GLN
104
A
GLY
105
n
109
GLY
105
A
ILE
106
n
110
ILE
106
A
ARG
107
n
111
ARG
107
A
ALA
108
n
112
ALA
108
A
TRP
109
n
113
TRP
109
A
VAL
110
n
114
VAL
110
A
ALA
111
n
115
ALA
111
A
TRP
112
n
116
TRP
112
A
ARG
113
n
117
ARG
113
A
ASN
114
n
118
ASN
114
A
ARG
115
n
119
ARG
115
A
CYS
116
n
120
CYS
116
A
GLN
117
n
121
GLN
117
A
ASN
118
n
122
ASN
118
A
ARG
119
n
123
ARG
119
A
ASP
120
n
124
ASP
120
A
VAL
121
n
125
VAL
121
A
ARG
122
n
126
ARG
122
A
GLN
123
n
127
GLN
123
A
TYR
124
n
128
TYR
124
A
VAL
125
n
129
VAL
125
A
GLN
126
n
130
GLN
126
A
GLY
127
n
131
GLY
127
A
CYS
128
n
132
CYS
128
A
GLY
129
n
133
GLY
129
A
VAL
130
n
134
VAL
130
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LYS
1
A
O
LYS
1
A
N
THR
40
A
N
THR
40
A
O
ALA
42
A
O
ALA
42
A
N
GLY
55
A
N
GLY
55
A
O
THR
52
A
O
THR
52
A
N
SER
61
A
N
SER
61
1
A
ARG
119
0.072
SIDE CHAIN
1
23.92
2.20
113.40
137.32
A
A
A
CA
CB
CG
GLU
GLU
GLU
4
4
4
N
1
-13.63
2.00
118.30
104.67
A
A
A
CG
CD
OE2
GLU
GLU
GLU
7
7
7
N
1
-4.03
0.50
120.30
116.27
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
10
10
10
N
1
4.15
0.50
120.30
124.45
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
10
10
10
N
1
-5.53
0.50
120.30
114.77
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
14
14
14
N
1
7.36
0.90
118.30
125.66
A
A
A
CB
CG
OD1
ASP
ASP
ASP
18
18
18
N
1
10.50
1.40
123.60
134.10
A
A
A
CD
NE
CZ
ARG
ARG
ARG
41
41
41
N
1
8.09
0.90
118.30
126.39
A
A
A
CB
CG
OD1
ASP
ASP
ASP
49
49
49
N
1
9.57
1.40
123.60
133.17
A
A
A
CD
NE
CZ
ARG
ARG
ARG
50
50
50
N
1
6.43
0.50
120.30
126.73
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
50
50
50
N
1
-3.04
0.50
120.30
117.26
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
50
50
50
N
1
10.13
1.50
110.10
120.23
A
A
A
CB
CA
C
ALA
ALA
ALA
73
73
73
N
A
B
B
1
15.34
2.10
122.30
137.64
A
A
A
C
N
CA
ARG
GLY
GLY
74
74
74
Y
1
10.13
0.90
118.30
128.43
A
A
A
CB
CG
OD1
ASP
ASP
ASP
87
87
87
N
1
-8.05
0.90
118.30
110.25
A
A
A
CB
CG
OD2
ASP
ASP
ASP
87
87
87
N
1
5.29
0.50
120.30
125.59
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
98
98
98
N
1
9.32
1.40
123.60
132.92
A
A
A
CD
NE
CZ
ARG
ARG
ARG
101
101
101
N
1
4.41
0.50
120.30
124.71
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
101
101
101
N
1
-5.41
0.90
118.30
112.89
A
A
A
CB
CG
OD2
ASP
ASP
ASP
102
102
102
N
1
4.92
0.50
120.30
125.22
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
113
113
113
N
1
-4.36
0.50
120.30
115.94
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
113
113
113
N
1
-4.30
0.50
120.30
116.00
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
115
115
115
N
1
-7.10
0.90
118.30
111.20
A
A
A
CB
CG
OD2
ASP
ASP
ASP
120
120
120
N
1
A
A
O
O
HOH
HOH
166
222
2.08
1_555
2_554
1
A
VAL
74
19.41
-99.62
1
A
ASN
75
-141.18
55.31
0.146
1.8
5.0
10744
1
1.8
5.0
82
1142
2
0
1058
0.015
0.015
0.039
0.039
refinement
PROLSQ
LYSOZYME (E.C.3.2.1.17) MUTANT WITH FOUR AMINO ACID RESIDUES (ARG 74A, GLY 74B, ASP 74C AND SER 74D) INSERTED BETWEEN VAL 74 AND ASN 75
STRUCTURAL AND FUNCTIONAL ANALYSES OF THE ARG-GLY-ASP SEQUENCE INTRODUCED INTO HUMAN LYSOZYME
1
N
N
2
N
N
2
N
N
3
N
N
A
ARG
5
A
ARG
5
HELX_P
A
ARG
14
A
ARG
14
1
A
10
A
LEU
25
A
LEU
25
HELX_P
A
GLU
35
A
GLU
35
1
B
11
A
SER
80
A
SER
84
HELX_P
A
LEU
85
A
LEU
89
5
E
6
A
ALA
90
A
ALA
94
HELX_P
A
VAL
99
A
VAL
103
1
C
10
A
VAL
110
A
VAL
114
HELX_P
A
CYS
116
A
CYS
120
1
D
7
disulf
2.031
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
128
A
SG
CYS
132
1_555
disulf
2.072
A
CYS
30
A
SG
CYS
30
1_555
A
CYS
116
A
SG
CYS
120
1_555
disulf
2.037
A
CYS
65
A
SG
CYS
65
1_555
A
CYS
81
A
SG
CYS
85
1_555
disulf
2.032
A
CYS
77
A
SG
CYS
81
1_555
A
CYS
95
A
SG
CYS
99
1_555
HYDROLASE(O-GLYCOSYL)
HYDROLASE(O-GLYCOSYL)
LYSC_HUMAN
UNP
1
1
P61626
MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSR
YWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV
19
144
1LZ5
1
126
P61626
A
1
1
130
1
INSERTION
ARG
74
1LZ5
A
A
P61626
UNP
75
1
INSERTION
GLY
74
1LZ5
B
A
P61626
UNP
76
1
INSERTION
ASP
74
1LZ5
C
A
P61626
UNP
77
1
INSERTION
SER
74
1LZ5
D
A
P61626
UNP
78
2
3
anti-parallel
anti-parallel
anti-parallel
A
LYS
1
A
LYS
1
A
PHE
3
A
PHE
3
A
TYR
38
A
TYR
38
A
THR
40
A
THR
40
A
ALA
42
A
ALA
42
A
ASN
46
A
ASN
46
A
SER
51
A
SER
51
A
GLY
55
A
GLY
55
A
ILE
59
A
ILE
59
A
SER
61
A
SER
61
BINDING SITE FOR RESIDUE CL A 131
Software
4
BINDING SITE FOR RESIDUE CL A 132
Software
3
A
SER
80
A
SER
84
4
1_555
A
ARG
107
A
ARG
111
4
4_457
A
HOH
232
D
HOH
4
1_555
A
HOH
241
D
HOH
4
1_555
A
ASN
27
A
ASN
27
3
4_457
A
ASN
66
A
ASN
66
3
1_555
A
SER
80
A
SER
84
3
1_555
19
P 21 21 21